BROMFENAC

BROMFENAC was reported 1449 times

BROMFENAC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LENTICULAR INJURY 2 0.1176
1 PRIMARY STABBING HEADACHE 5 0.0704
2 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST 1 0.0588
3 DIFFUSE UVEAL MELANOCYTIC PROLIFERATION 1 0.0526
4 FIBRIN ABNORMAL 1 0.0500
5 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 3 0.0411
6 AQUEOUS FIBRIN 2 0.0392
7 CORNEAL INFILTRATES 12 0.0382
8 PUPILLARY BLOCK 1 0.0312
9 EYE INFECTION INTRAOCULAR 2 0.0256
10 CORNEAL IRRITATION 2 0.0250
11 KERATITIS VIRAL 1 0.0244
12 ANTERIOR CHAMBER FIBRIN 3 0.0233
13 IRIS DISCOLOURATION 1 0.0217
14 INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION 1 0.0208
15 NEUROTROPHIC KERATOPATHY 1 0.0185
16 HYPOPYON 15 0.0181
17 PRODUCT GEL FORMATION 2 0.0164
18 INFECTIVE SCLERITIS 1 0.0111
19 VOCAL CORD CYST 1 0.0102
20 FUNDOSCOPY ABNORMAL 1 0.0096
21 VOGT-KOYANAGI-HARADA DISEASE 2 0.0091
22 THERMAL BURNS OF EYE 2 0.0088
23 PRECANCEROUS LESION OF DIGESTIVE TRACT 1 0.0088
24 CORNEAL EPITHELIUM DEFECT 5 0.0086
25 PERSISTENT CORNEAL EPITHELIAL DEFECT 1 0.0085
26 DACRYOCANALICULITIS 1 0.0085
27 DYSCHROMATOPSIA 7 0.0084
28 BILIRUBIN URINE PRESENT 1 0.0084
29 ANTERIOR CHAMBER CELL 6 0.0084
30 ATROPHY OF GLOBE 1 0.0078
31 PRODUCT DROPPER ISSUE 6 0.0076
32 CORNEAL OEDEMA 17 0.0076
33 TOXIC ANTERIOR SEGMENT SYNDROME 8 0.0073
34 INCISION SITE OEDEMA 1 0.0072
35 DERMATOCHALASIS 1 0.0068
36 PUNCTATE KERATITIS 6 0.0065
37 VACCINATION SITE SWELLING 1 0.0058
38 TONGUE FUNGAL INFECTION 1 0.0058
39 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1 0.0056
40 SYPHILIS 4 0.0055
41 EXCESSIVE EYE BLINKING 8 0.0054
42 PERSEVERATION 1 0.0054
43 SMOOTH MUSCLE ANTIBODY POSITIVE 1 0.0053
44 DEAFNESS PERMANENT 1 0.0051
45 CORNEAL DISORDER 11 0.0050
46 RETINAL ANEURYSM 1 0.0050
47 DYSMETRIA 3 0.0050
48 KERATITIS FUNGAL 1 0.0048
49 CORNEAL INFECTION 1 0.0046
50 LASER THERAPY 1 0.0044
51 CORNEAL OPACITY 6 0.0044
52 ANTERIOR CHAMBER FLARE 1 0.0043
53 CYSTOID MACULAR OEDEMA 8 0.0042
54 CORNEAL SCAR 2 0.0040
55 INFECTIVE TENOSYNOVITIS 1 0.0040
56 CORNEAL THINNING 1 0.0039
57 ENDOPHTHALMITIS 23 0.0038
58 METAMORPHOPSIA 7 0.0038
59 BACTERIAL ENDOPHTHALMITIS 1 0.0038
60 OCULAR TOXICITY 4 0.0036
61 PRODUCT CLOSURE ISSUE 2 0.0036
62 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
63 CARBUNCLE 1 0.0035
64 VOCAL CORD INFLAMMATION 1 0.0034
65 ANTERIOR CHAMBER INFLAMMATION 2 0.0034
66 SUPERIOR VENA CAVA SYNDROME 2 0.0033
67 RESTRICTIVE CARDIOMYOPATHY 1 0.0033
68 EYE ABSCESS 1 0.0033
69 IMPAIRED FASTING GLUCOSE 1 0.0033
70 PARAKERATOSIS 1 0.0031
71 POST PROCEDURAL CONTUSION 1 0.0030
72 ACANTHOSIS 1 0.0030
73 CONJUNCTIVAL OEDEMA 3 0.0029
74 EYE OEDEMA 7 0.0029
75 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 1 0.0028
76 PRODUCT DOSE CONFUSION 1 0.0028
77 PRODUCT DESIGN ISSUE 2 0.0028
78 VITRITIS 5 0.0027
79 ALTERNARIA INFECTION 1 0.0027
80 HUMAN HERPESVIRUS 6 INFECTION 5 0.0026
81 ACCELERATED HYPERTENSION 1 0.0026
82 EYE INFECTION FUNGAL 1 0.0026
83 POOR QUALITY PRODUCT ADMINISTERED 27 0.0026
84 ULCERATIVE KERATITIS 7 0.0026
85 PRODUCT CONTAINER ISSUE 21 0.0024
86 PROCEDURAL HEADACHE 1 0.0024
87 CORNEAL DYSTROPHY 1 0.0024
88 CARDITIS 1 0.0024
89 HYPOTONY OF EYE 1 0.0024
90 PRODUCT PHYSICAL CONSISTENCY ISSUE 13 0.0023
91 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
92 MACULAR HOLE 3 0.0022
93 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
94 OPEN FRACTURE 1 0.0021
95 LIQUID PRODUCT PHYSICAL ISSUE 15 0.0021
96 INTRAOCULAR LENS IMPLANT 1 0.0020
97 GLARE 1 0.0019
98 INJURY CORNEAL 1 0.0019
99 IRIS DISORDER 1 0.0019
100 CORNEAL EROSION 1 0.0019
101 BURSITIS INFECTIVE 1 0.0018
102 PRESBYOPIA 1 0.0018
103 BACTERIURIA 1 0.0018
104 HALO VISION 2 0.0018
105 TREATMENT FAILURE 146 0.0018
106 URINARY TRACT INFECTION FUNGAL 1 0.0017
107 EYE ULCER 1 0.0017
108 MEDICAL DEVICE REMOVAL 3 0.0017
109 CATATONIA 9 0.0017
110 EYE BURNS 1 0.0017
111 HYPOAESTHESIA EYE 1 0.0017
112 SPONDYLOARTHROPATHY 1 0.0017
113 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
114 SACRAL PAIN 1 0.0016
115 PRODUCT LEAKAGE 9 0.0016
116 URINARY SEDIMENT PRESENT 1 0.0016
117 MACULAR FIBROSIS 1 0.0015
118 EYE INFLAMMATION 14 0.0015
119 LICHEN SCLEROSUS 1 0.0015
120 CORNEAL ABRASION 2 0.0015
121 GRANULOMATOUS LIVER DISEASE 1 0.0014
122 FOREIGN BODY SENSATION IN EYES 9 0.0014
123 EYELID MARGIN CRUSTING 4 0.0014
124 GASTROINTESTINAL SCARRING 1 0.0014
125 ASTIGMATISM 2 0.0013
126 RETINAL INJURY 1 0.0013
127 CORNEAL TRANSPLANT 1 0.0013
128 KERATOPATHY 2 0.0013
129 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
130 SCLERITIS 2 0.0012
131 CHOROIDAL EFFUSION 1 0.0012
132 PROCEDURAL NAUSEA 1 0.0012
133 REACTION TO PRESERVATIVES 1 0.0012
134 PROSTATE CANCER METASTATIC 4 0.0012
135 INFUSION SITE OEDEMA 1 0.0012
136 SEROUS RETINAL DETACHMENT 1 0.0012
137 NON-INFECTIOUS ENDOPHTHALMITIS 1 0.0012
138 MYCOTIC ALLERGY 1 0.0012
139 PRODUCT COLOUR ISSUE 6 0.0012
140 CHOROIDAL NEOVASCULARISATION 1 0.0012
141 RETINITIS 2 0.0012
142 ENDOCRINE OPHTHALMOPATHY 1 0.0012
143 DRUG LEVEL FLUCTUATING 1 0.0011
144 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
145 VITREOUS FLOATERS 11 0.0011
146 EYE PAIN 63 0.0011
147 PRODUCT DELIVERY MECHANISM ISSUE 6 0.0011
148 VISUAL FIELD DEFECT 8 0.0011
149 SINUS NODE DYSFUNCTION 2 0.0011
150 INTRACRANIAL MASS 1 0.0011
151 HYPERMETROPIA 1 0.0011
152 RETINAL OEDEMA 2 0.0010
153 FOREIGN BODY IN EYE 1 0.0010
154 HEMIANOPIA 1 0.0010
155 EYE IRRITATION 58 0.0010
156 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
157 EYELID PAIN 2 0.0010
158 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
159 PRODUCT COATING ISSUE 1 0.0010
160 BRAIN STEM INFARCTION 1 0.0010
161 VITREOUS DETACHMENT 2 0.0009
162 INSTILLATION SITE REACTION 1 0.0009
163 MACULAR OEDEMA 5 0.0009
164 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
165 PRODUCT PACKAGING ISSUE 8 0.0008
166 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
167 EYELID IRRITATION 2 0.0008
168 INTRAOCULAR PRESSURE INCREASED 10 0.0008
169 DRUG PRESCRIBING ERROR 15 0.0008
170 RETINAL DEGENERATION 1 0.0008
171 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
172 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
173 SKIN WRINKLING 2 0.0007
174 INCISIONAL HERNIA 1 0.0007
175 OCULAR DISCOMFORT 8 0.0007
176 GLUTEN SENSITIVITY 1 0.0007
177 MUTISM 1 0.0007
178 COCCYDYNIA 1 0.0007
179 CATARACT OPERATION 4 0.0007
180 SUPERINFECTION 1 0.0007
181 REBOUND ACID HYPERSECRETION 2 0.0007
182 KERATITIS 2 0.0007
183 PRODUCT PHYSICAL ISSUE 13 0.0006
184 PRODUCT DEPOSIT 1 0.0006
185 IRIDOCYCLITIS 2 0.0006
186 LACRIMATION INCREASED 19 0.0006
187 OPTIC ATROPHY 1 0.0006
188 INFUSION SITE HAEMORRHAGE 2 0.0006
189 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
190 RETINAL THICKENING 1 0.0006
191 OCULAR HYPERAEMIA 28 0.0006
192 RECALLED PRODUCT 1 0.0006
193 PUPIL FIXED 1 0.0006
194 PAPILLARY THYROID CANCER 1 0.0006
195 LACK OF INJECTION SITE ROTATION 1 0.0006
196 INFUSION SITE DISCHARGE 1 0.0006
197 HISTOPLASMOSIS 1 0.0006
198 PRODUCT CONTAMINATION 2 0.0006
199 CONJUNCTIVAL HYPERAEMIA 2 0.0006
200 EXTRA DOSE ADMINISTERED 22 0.0005
201 DISORGANISED SPEECH 1 0.0005
202 PUPILLARY REFLEX IMPAIRED 1 0.0005
203 LYMPH NODE PAIN 1 0.0005
204 TRAUMATIC LUNG INJURY 1 0.0005
205 HYPERAEMIA 1 0.0005
206 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
207 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
208 VOCAL CORD DISORDER 1 0.0005
209 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 17 0.0005
210 EMPYEMA 1 0.0005
211 BLEPHARITIS 2 0.0005
212 SUDDEN HEARING LOSS 1 0.0005
213 IMPAIRED HEALING 16 0.0005
214 CHANGE OF BOWEL HABIT 1 0.0005
215 SELF-MEDICATION 2 0.0005
216 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
217 PHARYNGEAL ERYTHEMA 1 0.0005
218 PRODUCT DISPENSING ISSUE 2 0.0005
219 ABNORMAL SENSATION IN EYE 2 0.0005
220 EXOPHTHALMOS 1 0.0005
221 PARANOIA 8 0.0005
222 PRODUCT DISPENSING ERROR 10 0.0005
223 PHYSICAL DISABILITY 2 0.0005
224 PRODUCT LOT NUMBER ISSUE 1 0.0005
225 FAECES PALE 1 0.0004
226 PRODUCT STORAGE ERROR 39 0.0004
227 PRODUCT ADMINISTRATION ERROR 9 0.0004
228 PRODUCT USE COMPLAINT 7 0.0004
229 HEPATOCELLULAR DAMAGE 1 0.0004
230 SUSPECTED OFF LABEL USE 2 0.0004
231 UVEITIS 6 0.0004
232 DERMATITIS CONTACT 5 0.0004
233 RETINAL DETACHMENT 4 0.0004
234 EYE OPERATION 2 0.0004
235 HAEMANGIOMA 1 0.0004
236 NEPHROGENIC ANAEMIA 2 0.0004
237 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
238 SKIN ABRASION 2 0.0004
239 WRONG DOSE 1 0.0004
240 GLOMERULONEPHRITIS 1 0.0004
241 INSTILLATION SITE PAIN 1 0.0004
242 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
243 ANGLE CLOSURE GLAUCOMA 1 0.0004
244 MEAN CELL VOLUME INCREASED 1 0.0004
245 RETINAL DISORDER 1 0.0004
246 PHOTOPHOBIA 7 0.0004
247 ENCEPHALOPATHY 9 0.0004
248 CLONUS 1 0.0004
249 ORAL FUNGAL INFECTION 1 0.0004
250 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
251 RHINALGIA 1 0.0004
252 VITREOUS HAEMORRHAGE 1 0.0004
253 REBOUND EFFECT 4 0.0004
254 CATARACT 21 0.0004
255 PRODUCT DOSE OMISSION 23 0.0004
256 INJECTION SITE SCAR 1 0.0004
257 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
258 VOMITING PROJECTILE 1 0.0003
259 HAEMOTHORAX 1 0.0003
260 MADAROSIS 4 0.0003
261 TOOTH DISCOLOURATION 1 0.0003
262 HALLUCINATION, VISUAL 7 0.0003
263 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
264 IRITIS 1 0.0003
265 DYSCHEZIA 1 0.0003
266 MYDRIASIS 4 0.0003
267 POOR QUALITY DRUG ADMINISTERED 2 0.0003
268 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
269 LYMPHOCYTE COUNT INCREASED 1 0.0003
270 INJECTION SITE INFECTION 1 0.0003
271 DEAFNESS NEUROSENSORY 1 0.0003
272 ANXIETY DISORDER 1 0.0003
273 EYE SWELLING 11 0.0003
274 ECCHYMOSIS 2 0.0003
275 POOR VENOUS ACCESS 3 0.0003
276 EYE DISCHARGE 3 0.0003
277 MACULOPATHY 1 0.0003
278 GLOSSITIS 1 0.0003
279 RETINOPATHY 1 0.0003
280 EYE INFECTION 3 0.0003
281 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
282 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
283 INSURANCE ISSUE 4 0.0003
284 COMMUNICATION DISORDER 1 0.0003
285 THYROID MASS 1 0.0003
286 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
287 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
288 ATAXIA 3 0.0003
289 OBSTRUCTION 1 0.0003
290 TRIGGER FINGER 1 0.0002
291 EYE PRURITUS 8 0.0002
292 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
293 PRODUCT DOSE OMISSION ISSUE 69 0.0002
294 VISUAL IMPAIRMENT 29 0.0002
295 HORDEOLUM 1 0.0002
296 DEVICE DEFECTIVE 4 0.0002
297 CHAPPED LIPS 1 0.0002
298 TRANSAMINASES INCREASED 5 0.0002
299 GASTROINTESTINAL INFECTION 2 0.0002
300 PAPILLOEDEMA 1 0.0002
301 OROPHARYNGEAL DISCOMFORT 2 0.0002
302 CONJUNCTIVITIS 4 0.0002
303 VISUAL ACUITY REDUCED 7 0.0002
304 RECALLED PRODUCT ADMINISTERED 2 0.0002
305 GLAUCOMA 4 0.0002
306 PRODUCT QUALITY ISSUE 28 0.0002
307 INCORRECT DOSAGE ADMINISTERED 1 0.0002
308 HYPERVOLAEMIA 1 0.0002
309 DRY EYE 10 0.0002
310 VEIN DISORDER 1 0.0002
311 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
312 VULVOVAGINAL PRURITUS 1 0.0002
313 VISION BLURRED 27 0.0002
314 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
315 INITIAL INSOMNIA 2 0.0002
316 EAR DISCOMFORT 2 0.0002
317 VARICOSE VEIN 1 0.0002
318 PRODUCT USE ISSUE 36 0.0002
319 POLYARTHRITIS 1 0.0002
320 SCIATICA 3 0.0002
321 PHARYNGOLARYNGEAL PAIN 1 0.0002
322 BODY HEIGHT DECREASED 2 0.0002
323 OVERWEIGHT 1 0.0002
324 PRODUCT SIZE ISSUE 1 0.0002
325 ERYTHEMA OF EYELID 1 0.0002
326 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
327 PRODUCT PRESCRIBING ISSUE 4 0.0002
328 TIC 1 0.0002
329 HYPERKERATOSIS 1 0.0002
330 PROSTATIC DISORDER 1 0.0002
331 INTERMENSTRUAL BLEEDING 1 0.0002
332 CHROMATURIA 4 0.0002
333 PERIORBITAL SWELLING 1 0.0002
334 SCAR 3 0.0002
335 SKIN ATROPHY 1 0.0002
336 EYELID OEDEMA 2 0.0002
337 URINE ODOUR ABNORMAL 1 0.0002
338 PLEURISY 1 0.0002
339 MACULAR DEGENERATION 2 0.0002
340 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
341 LARYNGEAL OEDEMA 1 0.0002
342 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
343 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
344 PRE-EXISTING CONDITION IMPROVED 1 0.0002
345 SWELLING OF EYELID 1 0.0002
346 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
347 EAR PAIN 3 0.0002
348 APPLICATION SITE VESICLES 1 0.0002
349 RESPIRATORY TRACT INFECTION 4 0.0002
350 INCORRECT PRODUCT STORAGE 2 0.0002
351 WALKING AID USER 1 0.0002
352 SKIN MASS 1 0.0001
353 MENINGITIS 1 0.0001
354 TERMINAL STATE 1 0.0001
355 CHOLECYSTITIS CHRONIC 1 0.0001
356 IMPAIRED GASTRIC EMPTYING 2 0.0001
357 EYE MOVEMENT DISORDER 1 0.0001
358 HALLUCINATION 11 0.0001
359 AUTOIMMUNE HEPATITIS 1 0.0001
360 PAPULE 1 0.0001
361 SEASONAL ALLERGY 2 0.0001
362 RETINAL HAEMORRHAGE 1 0.0001
363 FAECES SOFT 1 0.0001
364 BLINDNESS TRANSIENT 1 0.0001
365 PSYCHOTIC DISORDER 4 0.0001
366 LIPASE INCREASED 1 0.0001
367 SHOCK 3 0.0001
368 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
369 FOOD ALLERGY 1 0.0001
370 CONCUSSION 1 0.0001
371 APHTHOUS ULCER 1 0.0001
372 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
373 FURUNCLE 1 0.0001
374 BLOOD DISORDER 1 0.0001
375 UTERINE CANCER 1 0.0001
376 SENSORY LOSS 1 0.0001
377 STENT PLACEMENT 1 0.0001
378 BLINDNESS 5 0.0001
379 EYE DISORDER 4 0.0001
380 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
381 SPINAL COMPRESSION FRACTURE 1 0.0001
382 DRUG LEVEL INCREASED 2 0.0001
383 INFUSION SITE ERYTHEMA 1 0.0001
384 SKIN ULCER 3 0.0001
385 NO ADVERSE EVENT 21 0.0001
386 BLOOD MAGNESIUM DECREASED 1 0.0001
387 CARDIAC MURMUR 1 0.0001
388 PRODUCT COMMUNICATION ISSUE 1 0.0001
389 BRADYCARDIA 6 0.0001
390 HEAD DISCOMFORT 2 0.0001
391 FACIAL PAIN 1 0.0001
392 HAEMOLYTIC ANAEMIA 1 0.0001
393 GASTROENTERITIS VIRAL 2 0.0001
394 DRUG DOSE OMISSION 18 0.0001
395 PRODUCT DISTRIBUTION ISSUE 1 0.0001
396 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
397 HEPATIC CIRRHOSIS 2 0.0001
398 SPUTUM DISCOLOURED 1 0.0001
399 INTENTIONAL DOSE OMISSION 3 0.0001
400 PRODUCT SUBSTITUTION ISSUE 6 0.0001
401 HYPERCHOLESTEROLAEMIA 1 0.0001
402 HERNIA 2 0.0001
403 DIZZINESS POSTURAL 1 0.0001
404 VITAMIN D DEFICIENCY 1 0.0001
405 INFLAMMATORY BOWEL DISEASE 1 0.0001
406 PHARYNGEAL SWELLING 1 0.0001
407 LIGAMENT SPRAIN 1 0.0001
408 INABILITY TO AFFORD MEDICATION 1 0.0001
409 COMPLICATION OF DEVICE INSERTION 2 0.0001
410 VAGINAL DISCHARGE 1 0.0001
411 BODY TEMPERATURE INCREASED 2 0.0001
412 DRUG ADMINISTRATION ERROR 3 0.0001
413 NEUTROPHIL COUNT INCREASED 1 0.0001
414 WEIGHT FLUCTUATION 1 0.0001
415 ECZEMA 5 0.0001
416 TRANSFUSION 1 0.0001
417 JOINT DISLOCATION 1 0.0001
418 IRRITABLE BOWEL SYNDROME 2 0.0001
419 HEREDITARY ANGIOEDEMA 1 0.0001
420 BALANCE DISORDER 8 0.0001
421 OEDEMA 5 0.0001
422 SKIN LACERATION 1 0.0001
423 BACK INJURY 1 0.0001
424 OESOPHAGITIS 1 0.0001
425 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
426 BLOOD GLUCOSE FLUCTUATION 1 0.0001
427 APPLICATION SITE PAIN 2 0.0001
428 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
429 HEPATOTOXICITY 2 0.0001
430 PRODUCT AVAILABILITY ISSUE 2 0.0001
431 SCAB 1 0.0001
432 OFF LABEL USE 75 0.0001
433 SPLENOMEGALY 1 0.0001
434 THERAPY INTERRUPTED 6 0.0001
435 MUSCLE RIGIDITY 1 0.0001
436 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
437 INCORRECT DOSE ADMINISTERED 19 0.0001
438 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
439 LOCALISED INFECTION 2 0.0001
440 ADRENAL INSUFFICIENCY 1 0.0001
441 CEREBRAL INFARCTION 2 0.0001
442 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
443 HYPERCALCAEMIA 1 0.0001
444 ABNORMAL WEIGHT GAIN 1 0.0001
445 APPLICATION SITE IRRITATION 1 0.0001
446 AGEUSIA 2 0.0001
447 DYSARTHRIA 3 0.0001
448 INTESTINAL OBSTRUCTION 3 0.0001
449 ILLNESS 8 0.0001
450 INFUSION SITE PAIN 1 0.0001
451 ANOREXIA 1 0.0001
452 EXPOSURE VIA SKIN CONTACT 2 0.0001
453 INJECTION SITE INDURATION 1 0.0001
454 DIPLOPIA 2 0.0001
455 BLOOD CREATININE INCREASED 5 0.0001
456 DEAFNESS 2 0.0001
457 IMMUNE SYSTEM DISORDER 1 0.0001
458 ANKYLOSING SPONDYLITIS 1 0.0001
459 SARS-COV-2 TEST POSITIVE 1 0.0001
460 DRUG INTERACTION 12 0.0001
461 EYE HAEMORRHAGE 1 0.0001
462 MALIGNANT MELANOMA 1 0.0001
463 QUALITY OF LIFE DECREASED 1 0.0001
464 THROAT TIGHTNESS 2 0.0001
465 GINGIVAL BLEEDING 1 0.0001
466 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
467 CORONARY ARTERY OCCLUSION 1 0.0001
468 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
469 MASS 1 0.0001
470 BURNING SENSATION 5 0.0001
471 BLISTER 4 0.0001
472 DEVICE OCCLUSION 1 0.0001
473 BLINDNESS UNILATERAL 1 0.0001
474 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
475 FLATULENCE 4 0.0001
476 HYPERHIDROSIS 9 0.0001
477 CARDIOGENIC SHOCK 1 0.0001
478 IMPAIRED QUALITY OF LIFE 1 0.0001
479 GASTROENTERITIS 1 0.0001
480 UNDERDOSE 5 0.0001
481 SURGERY 4 0.0001
482 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
483 IMMUNODEFICIENCY 1 0.0001
484 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
485 HAEMORRHAGE INTRACRANIAL 1 0.0001
486 ECONOMIC PROBLEM 1 0.0001
487 OSTEOPENIA 1 0.0001
488 DISCOMFORT 4 0.0001
489 TINNITUS 3 0.0001
490 DEVICE RELATED INFECTION 1 0.0001
491 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
492 THYROID DISORDER 1 0.0001
493 HYPERSENSITIVITY 12 0.0001
494 LIMB DISCOMFORT 2 0.0001
495 BRAIN FOG 1 0.0001
496 HEAD INJURY 2 0.0001
497 RESPIRATORY TRACT CONGESTION 1 0.0001
498 ABSCESS 1 0.0001
499 BLOOD GLUCOSE DECREASED 3 0.0001
500 MUSCLE TIGHTNESS 1 0.0001
501 PHOTOSENSITIVITY REACTION 1 0.0001
502 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
503 INFUSION RELATED REACTION 4 0.0001
504 VIRAL INFECTION 2 0.0001
505 BLOOD UREA INCREASED 1 0.0001
506 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
507 THERAPY CESSATION 3 0.0001
508 INFLAMMATION 3 0.0001
509 LOCAL SWELLING 1 0.0001
510 AMENORRHOEA 1 0.0001
511 LYMPHADENOPATHY 2 0.0001
512 DRUG ERUPTION 1 0.0001
513 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
514 CONDITION AGGRAVATED 17 0.0001
515 OSTEOMYELITIS 1 0.0001
516 END STAGE RENAL DISEASE 1 0.0001
517 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
518 ANAPHYLACTIC REACTION 3 0.0001
519 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
520 BLOOD GLUCOSE ABNORMAL 1 0.0001
521 HEPATIC STEATOSIS 1 0.0001
522 NECK PAIN 3 0.0001
523 BACTERIAL INFECTION 1 0.0001
524 MIDDLE INSOMNIA 1 0.0001
525 DYSPNOEA EXERTIONAL 2 0.0001
526 BLOOD URINE PRESENT 1 0.0001
527 PROTEINURIA 1 0.0001
528 INCREASED APPETITE 1 0.0001
529 ACUTE RESPIRATORY FAILURE 1 0.0001
530 ERUCTATION 1 0.0001
531 DYSPHONIA 3 0.0001
532 DISABILITY 1 0.0001
533 SINUS DISORDER 1 0.0001
534 HAEMATOCRIT DECREASED 1 0.0001
535 BLOOD PRESSURE ABNORMAL 1 0.0001
536 UPPER LIMB FRACTURE 1 0.0001
537 SYNCOPE 5 0.0000
538 FULL BLOOD COUNT DECREASED 1 0.0000
539 FEEDING DISORDER 1 0.0000
540 TASTE DISORDER 1 0.0000
541 SINUSITIS 5 0.0000
542 PRODUCT PREPARATION ERROR 1 0.0000
543 OSTEOPOROSIS 2 0.0000
544 DRUG INEFFECTIVE 64 0.0000
545 ROAD TRAFFIC ACCIDENT 2 0.0000
546 DERMATITIS 1 0.0000
547 KNEE ARTHROPLASTY 1 0.0000
548 MOUTH ULCERATION 1 0.0000
549 OSTEOARTHRITIS 2 0.0000
550 JOINT INJURY 1 0.0000
551 IMPAIRED WORK ABILITY 1 0.0000
552 LIVER FUNCTION TEST INCREASED 1 0.0000
553 HYPOACUSIS 2 0.0000
554 SKIN CANCER 1 0.0000
555 PRURITUS GENERALISED 1 0.0000
556 SWELLING FACE 3 0.0000
557 DEVICE DISLOCATION 2 0.0000
558 BLOOD PRESSURE INCREASED 7 0.0000
559 ANGIOEDEMA 2 0.0000
560 NEOPLASM MALIGNANT 3 0.0000
561 ORAL PAIN 1 0.0000
562 SNEEZING 1 0.0000
563 PERICARDIAL EFFUSION 1 0.0000
564 ARRHYTHMIA 2 0.0000
565 PRODUCT PRESCRIBING ERROR 1 0.0000
566 RASH ERYTHEMATOUS 2 0.0000
567 HEADACHE 26 0.0000
568 RASH 18 0.0000
569 FIBROMYALGIA 1 0.0000
570 PRESYNCOPE 1 0.0000
571 OEDEMA PERIPHERAL 5 0.0000
572 LUNG DISORDER 2 0.0000
573 COVID-19 7 0.0000
574 PRODUCT COMPLAINT 1 0.0000
575 CARDIOVASCULAR DISORDER 1 0.0000
576 DIABETES MELLITUS 3 0.0000
577 INJECTION SITE SWELLING 3 0.0000
578 HYPOPHAGIA 1 0.0000
579 HAEMOGLOBIN DECREASED 4 0.0000
580 ABDOMINAL PAIN UPPER 8 0.0000
581 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
582 SPEECH DISORDER 2 0.0000
583 APPLICATION SITE ERYTHEMA 1 0.0000
584 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
585 MUSCLE SPASMS 7 0.0000
586 DIZZINESS 19 0.0000
587 ANHEDONIA 1 0.0000
588 GASTRITIS 1 0.0000
589 NASOPHARYNGITIS 7 0.0000
590 DEPRESSED MOOD 2 0.0000
591 INJECTION SITE BRUISING 3 0.0000
592 DEHYDRATION 5 0.0000
593 DRY SKIN 5 0.0000
594 THROMBOSIS 3 0.0000
595 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
596 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
597 PALLOR 1 0.0000
598 CONSTIPATION 8 0.0000
599 MOOD ALTERED 1 0.0000
600 SKIN LESION 1 0.0000
601 INFLUENZA LIKE ILLNESS 3 0.0000
602 PROCEDURAL PAIN 1 0.0000
603 MEDICATION ERROR 2 0.0000
604 INFLUENZA 4 0.0000
605 SEPSIS 4 0.0000
606 COUGH 10 0.0000
607 RED BLOOD CELL COUNT DECREASED 1 0.0000
608 ANGINA PECTORIS 1 0.0000
609 HYPERSOMNIA 1 0.0000
610 FATIGUE 27 0.0000
611 BACK PAIN 8 0.0000
612 NEEDLE ISSUE 1 0.0000
613 DYSSTASIA 1 0.0000
614 PALPITATIONS 4 0.0000
615 LABORATORY TEST ABNORMAL 1 0.0000
616 RENAL INJURY 1 0.0000
617 RESPIRATORY DISORDER 1 0.0000
618 ADVERSE DRUG REACTION 3 0.0000
619 FEELING ABNORMAL 8 0.0000
620 BLOOD POTASSIUM DECREASED 1 0.0000
621 THERAPEUTIC RESPONSE DECREASED 2 0.0000
622 ILL-DEFINED DISORDER 2 0.0000
623 CARDIAC DISORDER 3 0.0000
624 SWOLLEN TONGUE 1 0.0000
625 ASTHENIA 12 0.0000
626 DYSPHAGIA 3 0.0000
627 CYSTITIS 1 0.0000
628 HYPOTHYROIDISM 1 0.0000
629 ARTHRALGIA 13 0.0000
630 PRURITUS 12 0.0000
631 NIGHT SWEATS 1 0.0000
632 RHINORRHOEA 2 0.0000
633 PAIN 19 0.0000
634 STAPHYLOCOCCAL INFECTION 1 0.0000
635 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
636 EXPIRED PRODUCT ADMINISTERED 1 0.0000
637 FUNGAL INFECTION 1 0.0000
638 URINARY RETENTION 1 0.0000
639 INJECTION SITE PRURITUS 2 0.0000
640 HEPATIC ENZYME INCREASED 2 0.0000
641 URINARY TRACT INFECTION 5 0.0000
642 MEMORY IMPAIRMENT 4 0.0000
643 INJECTION SITE REACTION 2 0.0000
644 NIGHTMARE 1 0.0000
645 DELIRIUM 1 0.0000
646 DEVICE USE ERROR 1 0.0000
647 HYPERKALAEMIA 1 0.0000
648 INJURY 2 0.0000
649 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
650 MOBILITY DECREASED 2 0.0000
651 INFECTION 4 0.0000
652 CRYING 1 0.0000
653 C-REACTIVE PROTEIN INCREASED 1 0.0000
654 HYPERGLYCAEMIA 1 0.0000
655 ACCIDENTAL OVERDOSE 1 0.0000
656 AGITATION 2 0.0000
657 DYSURIA 1 0.0000
658 FALL 9 0.0000
659 HEPATIC FUNCTION ABNORMAL 1 0.0000
660 EPISTAXIS 2 0.0000
661 UNEVALUABLE EVENT 2 0.0000
662 MUSCULAR WEAKNESS 3 0.0000
663 COLITIS 1 0.0000
664 ACNE 2 0.0000
665 CHRONIC KIDNEY DISEASE 2 0.0000
666 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
667 SEIZURE 3 0.0000
668 PLASMA CELL MYELOMA 1 0.0000
669 ARTHRITIS 2 0.0000
670 NAUSEA 20 0.0000
671 ABNORMAL BEHAVIOUR 1 0.0000
672 JOINT SWELLING 3 0.0000
673 CONFUSIONAL STATE 4 0.0000
674 DRY MOUTH 2 0.0000
675 LUNG NEOPLASM MALIGNANT 1 0.0000
676 ERYTHEMA 5 0.0000
677 POLLAKIURIA 1 0.0000
678 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
679 URTICARIA 4 0.0000
680 PAIN IN EXTREMITY 7 0.0000
681 SKIN EXFOLIATION 2 0.0000
682 VAGINAL HAEMORRHAGE 1 0.0000
683 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
684 RENAL FAILURE 3 0.0000
685 PULMONARY OEDEMA 1 0.0000
686 GASTROINTESTINAL DISORDER 2 0.0000
687 DEVICE ISSUE 2 0.0000
688 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
689 THROAT IRRITATION 1 0.0000
690 DEPRESSION 5 0.0000
691 SKIN IRRITATION 1 0.0000
692 NEPHROLITHIASIS 1 0.0000
693 SKIN DISCOLOURATION 1 0.0000
694 HYPOKALAEMIA 1 0.0000
695 OROPHARYNGEAL PAIN 2 0.0000
696 CHEST PAIN 4 0.0000
697 ABDOMINAL PAIN 5 0.0000
698 RENAL DISORDER 1 0.0000
699 DISEASE RECURRENCE 1 0.0000
700 GAIT DISTURBANCE 4 0.0000
701 CONTUSION 2 0.0000
702 DRUG INTOLERANCE 2 0.0000
703 INTERSTITIAL LUNG DISEASE 1 0.0000
704 MALAISE 9 0.0000
705 DYSPEPSIA 2 0.0000
706 HEART RATE INCREASED 2 0.0000
707 LEUKOPENIA 1 0.0000
708 CELLULITIS 1 0.0000
709 CHEST DISCOMFORT 2 0.0000
710 PERIPHERAL SWELLING 3 0.0000
711 DYSPNOEA 11 0.0000
712 ABDOMINAL DISTENSION 2 0.0000
713 NERVOUSNESS 1 0.0000
714 PANCREATITIS 1 0.0000
715 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
716 INSOMNIA 5 0.0000
717 DISTURBANCE IN ATTENTION 1 0.0000
718 TREATMENT NONCOMPLIANCE 1 0.0000
719 ARTHROPATHY 1 0.0000
720 WEIGHT DECREASED 5 0.0000
721 ABDOMINAL DISCOMFORT 3 0.0000
722 CEREBROVASCULAR ACCIDENT 3 0.0000
723 MYALGIA 3 0.0000
724 RHEUMATOID ARTHRITIS 2 0.0000
725 HERPES ZOSTER 1 0.0000
726 DECREASED APPETITE 4 0.0000
727 BONE PAIN 1 0.0000
728 CHILLS 2 0.0000
729 NASAL CONGESTION 1 0.0000
730 BLADDER CANCER 1 0.0000
731 WHEEZING 1 0.0000
732 EMOTIONAL DISTRESS 2 0.0000
733 STOMATITIS 1 0.0000
734 PLEURAL EFFUSION 1 0.0000
735 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
736 INJECTION SITE ERYTHEMA 2 0.0000
737 BLOOD GLUCOSE INCREASED 3 0.0000
738 ANAEMIA 3 0.0000
739 PNEUMONIA 5 0.0000
740 DEEP VEIN THROMBOSIS 1 0.0000
741 PSORIASIS 2 0.0000
742 HYPOTENSION 3 0.0000
743 VOMITING 7 0.0000
744 SLEEP DISORDER 1 0.0000
745 HYPERTENSION 3 0.0000
746 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
747 OVERDOSE 3 0.0000
748 RESPIRATORY FAILURE 1 0.0000
749 BRONCHITIS 1 0.0000
750 DYSGEUSIA 1 0.0000
751 HYPOAESTHESIA 2 0.0000
752 HOT FLUSH 1 0.0000
753 ACUTE KIDNEY INJURY 2 0.0000
754 DRUG DOSE OMISSION BY DEVICE 1 0.0000
755 INJECTION SITE HAEMORRHAGE 1 0.0000
756 CARDIAC FAILURE 1 0.0000
757 PROSTATE CANCER 1 0.0000
758 DIARRHOEA 8 0.0000
759 TREMOR 2 0.0000
760 RENAL IMPAIRMENT 1 0.0000
761 MUSCULOSKELETAL STIFFNESS 1 0.0000
762 BREAST CANCER 1 0.0000
763 SWELLING 1 0.0000
764 ANXIETY 3 0.0000
765 PULMONARY EMBOLISM 1 0.0000
766 NEUROPATHY PERIPHERAL 1 0.0000
767 ATRIAL FIBRILLATION 1 0.0000
768 ALOPECIA 2 0.0000
769 INJECTION SITE PAIN 3 0.0000
770 HAEMORRHAGE 1 0.0000
771 PLATELET COUNT DECREASED 1 0.0000
772 THROMBOCYTOPENIA 1 0.0000
773 WEIGHT INCREASED 2 0.0000
774 LOSS OF CONSCIOUSNESS 1 0.0000
775 HOSPITALISATION 1 0.0000
776 PARAESTHESIA 1 0.0000
777 TOXICITY TO VARIOUS AGENTS 1 0.0000
778 PYREXIA 2 0.0000
779 SOMNOLENCE 1 0.0000
780 DEATH 4 0.0000